Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis: A Swiss Multicenter Study Prospective, Controlled, Single-arm, Open-label, Multi-centre, Phase IV Study
Latest Information Update: 21 Nov 2014
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 21 Jan 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 23 Oct 2012 New trial record